The costs associated with adverse event procedures for an international HIV clinical trial determined by activity-based costing

Journal of Acquired Immune Deficiency Syndromes

Volumn 46, Issue 4, 2007, Pages 426-432

  Chou, Victoria B ^a   Omer, Saad B ^b   Hussain, Hamidah ^b   Mugasha, Christine ^c   Musisi, Maria ^c   Mmiro, Francis ^c   Musoke, Philippa ^c   Jackson, J Brooks ^a   Guay, Laura A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c MAKERERE UNIVERSITY   (Uganda)

Author keywords

Activity based costing; Adverse events; HIV clinical trial; International research; Study conduct costs

Indexed keywords

NEVIRAPINE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; COST OF ILLNESS; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEMATOLOGIC DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; MONOTHERAPY; NEUTROPENIA; PATIENT CARE; PERINATAL CARE; PREGNANCY COMPLICATION; PRIORITY JOURNAL; UPPER RESPIRATORY TRACT INFECTION; VIRUS TRANSMISSION;

ADULT; CHILD; COST OF ILLNESS; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; PREGNANCY; UGANDA;

EID: 36048957861     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318156ee37     Document Type: Article

References (12)

1. Merson MH. The HIV-AIDS pandemic at 25 - the global response. N Engl J Med. 2006;354:2414-2417.
2. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747-1757.
3. Bekker LG, Wood R. The natural history of HIV infection in Africa. S Afr Med J. 2006;96:526-529.
4. Hawkins H, Langer J, Padua E, et al. Activity-based costing via an information system: an application created for a breast imaging center. J Digit Imaging. 2001;14:194.
5. Vohr BR, Oh W, Stewart EJ, et al. Comparison of costs and referral rates of 3 universal newborn hearing screening protocols. J Pediatr. 2001;139:238-244.
6. Samant RS, Dunscombe PB, Roberts GH. A cost-outcome analysis of long-term adjuvant goserelin in addition to radiotherapy for locally advanced prostate cancer. Urol Oncol. 2003;21:171-177.
7. Dowless RM. Using activity-based costing to guide strategic decision making. Healthc Financ Manage. 1997;51:86-90.
8. Gabram SGA, Mendola RA. Why activity-based costing works. Physician Exec. 1997;23:31-37.
9. Division of AIDS, NIAID, NIH. Adult toxicity tables, tables for grading severity of pediatric adverse experiences. Available at: http://rcc.techres.com/ tox_tables.htm.
10. Smith MW, Barnett PG. Direct measurement of health care costs. Med Care Res Rev. 2003;60(3 Suppl):74S-91S.
11. OANDA, The Currency Site [database online]. New York, NY: The OANDA Corporation, 1996-2007. Available at: www.oanda.com. Accessed July 26, 2006.
12. Erdmann J. Researchers facing increasing costs for clinical research, with few solutions. J Natl Cancer Inst. 2007;97:1492-1494.